← FDA DRUG APPROVALS

FDA ANDA · ANDA070195

VALPROIC ACID

Sponsor: SCHERER RP

APPLICATION
ANDA070195
TYPE
ANDA
ORIGINAL APPROVAL
1987-07-02
LATEST ACTION
2001-07-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

VALPROIC ACIDDiscontinued
VALPROIC ACID 250MG · CAPSULE · ORAL

Approval history

2001-07-05Manufacturing (CMC) · Supplement 9AP
1999-03-12Manufacturing (CMC) · Supplement 8AP
1992-07-23Labeling · Supplement 7AP
1992-01-10Labeling · Supplement 6AP
1991-11-27Manufacturing (CMC) · Supplement 5AP
1991-11-27Manufacturing (CMC) · Supplement 4AP
1987-09-23Manufacturing (CMC) · Supplement 3AP
1987-09-23Manufacturing (CMC) · Supplement 2AP
1987-07-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →